Natalia G. Uskova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natalia G. Uskova has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
- Nikolay Sergeevich Grachev
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of the Russian Federation
26 shared publications - Dmitriy G. Akhaladze
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of the Russian Federation
24 shared publications - Sergey R. Talypov
National Scientific and Practical Center for Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Moscow, Russia
14 shared publications - Nikolay N. Merkulov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
13 shared publications - Denis Y. Kachanov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
12 shared publications - Gavriil S. Rabaev
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
12 shared publications
Latest Publications
- 9 October 2026
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 105 (5)
DEVELOPMENT OF CONSENSUS RECOMMENDATIONS ON THE SURGICAL MANAGEMENT OF PERINEAL SOFT-TISSUE INFECTIONS IN CHILDREN WITH SEVERE CYTOPENIA (MODIFIED DELPHI METHOD)
In children, perineal soft-tissue infections in a state of severe cytopenia due to high-dose chemotherapy and in the early post-transplant period (0–100 days after hematopoietic stem cell transplantation, HSCT) are among the most dangerous infectious complications: in a retrospective analysis of treatment outcomes in 399 children after HSCT, a perianal infection site significantly increased sepsis-related mortality before engraftment (30.8%, p=0.029). The clinical course of such infections in immunocompromised children differs substantially: they are more often polymicrobial (75% vs 58% in immunocompetent patients), and typical pain is frequently blunted, delaying diagnosis. Mortality in necrotizing soft-tissue infections in children reaches 16%. Cases of fulminant spread of inflammation from the external genitalia to the scrotum, perianal tissues, thighs and anterior abdominal wall within 36 hours have been reported. Surgical treatment plays a key role in controlling such infections, yet the specialized surgical literature on the subject is limited mostly to isolated observations and small case series, and current clinical guidelines do not detail surgical tactics for this condition. Given these gaps, we conducted a study using a modified Delphi method aimed at developing consensus recommendations on the surgical management of perineal soft-tissue infections in children in the early post-transplant period. The goal of the work was to standardize the diagnosis and treatment of such patients using contemporary methods, including negative pressure wound therapy. The working group comprised 39 leading pediatric oncosurgeons and transplant specialists from our country; the first-round questionnaire was completed by all 39 experts. The results include 39 statements, of which 37 reached a strong level of consensus, one a moderate level, and one a weak level (published owing to its practical relevance). The recommendations cover the minimum diagnostic work-up for suspected perineal infection after HSCT, principles of the primary operation and staged debridements, wound management and negative pressure wound therapy, indications for colostomy, referral to allied specialists, and timing of reconstructive procedures. We hope that this work will help improve the quality of surgical care for children in the early post-HSCT period and reduce complication and mortality rates.
- 9 October 2026
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 105 (5)
DEVELOPMENT OF CONSENSUS RECOMMENDATIONS ON THE SURGICAL MANAGEMENT OF PERINEAL SOFT-TISSUE INFECTIONS IN CHILDREN WITH SEVERE CYTOPENIA (MODIFIED DELPHI METHOD)
In children, perineal soft-tissue infections in a state of severe cytopenia due to high-dose chemotherapy and in the early post-transplant period (0–100 days after hematopoietic stem cell transplantation, HSCT) are among the most dangerous infectious complications: in a retrospective analysis of treatment outcomes in 399 children after HSCT, a perianal infection site significantly increased sepsis-related mortality before engraftment (30.8%, p=0.029). The clinical course of such infections in immunocompromised children differs substantially: they are more often polymicrobial (75% vs 58% in immunocompetent patients), and typical pain is frequently blunted, delaying diagnosis. Mortality in necrotizing soft-tissue infections in children reaches 16%. Cases of fulminant spread of inflammation from the external genitalia to the scrotum, perianal tissues, thighs and anterior abdominal wall within 36 hours have been reported. Surgical treatment plays a key role in controlling such infections, yet the specialized surgical literature on the subject is limited mostly to isolated observations and small case series, and current clinical guidelines do not detail surgical tactics for this condition. Given these gaps, we conducted a study using a modified Delphi method aimed at developing consensus recommendations on the surgical management of perineal soft-tissue infections in children in the early post-transplant period. The goal of the work was to standardize the diagnosis and treatment of such patients using contemporary methods, including negative pressure wound therapy. The working group comprised 39 leading pediatric oncosurgeons and transplant specialists from our country; the first-round questionnaire was completed by all 39 experts. The results include 39 statements, of which 37 reached a strong level of consensus, one a moderate level, and one a weak level (published owing to its practical relevance). The recommendations cover the minimum diagnostic work-up for suspected perineal infection after HSCT, principles of the primary operation and staged debridements, wound management and negative pressure wound therapy, indications for colostomy, referral to allied specialists, and timing of reconstructive procedures. We hope that this work will help improve the quality of surgical care for children in the early post-HSCT period and reduce complication and mortality rates.
- Open Access
- 28 September 2026
- Published by ECO-Vector LLC (Publications) in Digital Diagnostics
- Vol. 7 (3) , 296-310
Assessment of the accuracy of lung lesions diagnosis in adolescents with osteosarcoma using artificial intelligence: a cross-sectional study
INTRODUCTION: Pulmonary metastases in osteosarcoma are the leading cause of death. The accurate diagnosis of lesions on chest computed tomography is critical for staging disseminated disease and planning surgical treatment. The use of artificial intelligence to detect pulmonary lesions improves diagnostic accuracy and reduces the likelihood of missing metastases. AIM: to evaluate the accuracy of diagnosing pulmonary lesions on chest computed tomography scans using an artificial intelligence model in adolescents with osteosarcoma. METHODS: A retrospective assessment of computed tomography scans of adolescents with osteosarcoma was performed in a multicenter cross-sectional study. A pathological lesion of medium size of ≥ 4 mm was considered as the target finding. An artificial intelligence algorithm previously trained on a dataset of adult patients was assessed for its diagnostic accuracy. The number of false-positive and false-negative results was determined; sensitivity, specificity, accuracy, area under the receiver operating characteristic curve, positive predictive value, negative predictive value, and F1-score were also calculated. Based on the obtained results, the algorithm efficiency was assessed. RESULTS: 248 computed tomography scans of adolescents with osteosarcoma were analyzed. The following results were obtained: the artificial intelligence algorithm showed false-positive findings in 5 cases (2.02%), false-negative findings in 34 cases (13.71%), and a correct result—both true positive and true negative—in 209 cases (84.27%). The diagnostic accuracy of the algorithm was 0.843 (95% confidence interval: 0.794-0.887). Applying the artificial intelligence model in a radiologist’s practice for a specific clinical task would increase the sensitivity from 0.805 to 0.891 while reducing the absolute number of false-negative results by 8.59% and the relative decrease by 44%. CONCLUSION: The obtained results indicate the potential clinical utility of the artificial intelligence algorithm for diagnosing pulmonary metastases in adolescent patients with osteosarcoma. However, they also underscore the persisting statistical uncertainty and the need for validation in a larger and more representative cohort.
- 28 September 2026
- Published by ECO-Vector LLC (Publications) in Digital Diagnostics
- Vol. 7 (3) , 296-310
Open AccessAssessment of the accuracy of lung lesions diagnosis in adolescents with osteosarcoma using artificial intelligence: a cross-sectional study
INTRODUCTION: Pulmonary metastases in osteosarcoma are the leading cause of death. The accurate diagnosis of lesions on chest computed tomography is critical for staging disseminated disease and planning surgical treatment. The use of artificial intelligence to detect pulmonary lesions improves diagnostic accuracy and reduces the likelihood of missing metastases. AIM: to evaluate the accuracy of diagnosing pulmonary lesions on chest computed tomography scans using an artificial intelligence model in adolescents with osteosarcoma. METHODS: A retrospective assessment of computed tomography scans of adolescents with osteosarcoma was performed in a multicenter cross-sectional study. A pathological lesion of medium size of ≥ 4 mm was considered as the target finding. An artificial intelligence algorithm previously trained on a dataset of adult patients was assessed for its diagnostic accuracy. The number of false-positive and false-negative results was determined; sensitivity, specificity, accuracy, area under the receiver operating characteristic curve, positive predictive value, negative predictive value, and F1-score were also calculated. Based on the obtained results, the algorithm efficiency was assessed. RESULTS: 248 computed tomography scans of adolescents with osteosarcoma were analyzed. The following results were obtained: the artificial intelligence algorithm showed false-positive findings in 5 cases (2.02%), false-negative findings in 34 cases (13.71%), and a correct result—both true positive and true negative—in 209 cases (84.27%). The diagnostic accuracy of the algorithm was 0.843 (95% confidence interval: 0.794-0.887). Applying the artificial intelligence model in a radiologist’s practice for a specific clinical task would increase the sensitivity from 0.805 to 0.891 while reducing the absolute number of false-negative results by 8.59% and the relative decrease by 44%. CONCLUSION: The obtained results indicate the potential clinical utility of the artificial intelligence algorithm for diagnosing pulmonary metastases in adolescent patients with osteosarcoma. However, they also underscore the persisting statistical uncertainty and the need for validation in a larger and more representative cohort.
- Open Access
- 19 August 2026
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 25 (3) , 22-33
Prognostic factors in pediatric osteosarcoma presenting with pulmonary metastasis: experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
Introduction. Approximately 20% of newly diagnosed pediatric patients with high-grade osteosarcoma present with metastatic disease, with the lungs being the predominant site of dissemination. In the absence of universally accepted criteria for defining pulmonary metastases and assessing the resectability of metastatic lesions, treatment strategies for metastatic osteosarcoma remain highly individualized and depend on the experience of the treating institution. Objective – to evaluate clinicopathological characteristics and outcomes of osteosarcoma patients presenting with pulmonary metastases, and to identify prognostic factors associated with survival. Materials and methods. The study included newly diagnosed pediatric patients with histologically confirmed high-grade osteosarcoma and isolated pulmonary metastases, prospectively registered at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology between January 1, 2012, and December 31, 2023. All patients received specific therapy according to the MAP regimen (based on the EURAMOS-1 protocol). Treatment outcomes were evaluated by event-free survival (EFS) and overall survival (OS) rates, calculated using the Kaplan–Meier method. Results. Among 354 patients with high-grade osteosarcoma, isolated pulmonary metastases were identified in 96 patients (27.1%). The 5-year OS and EFS rates for the entire cohort were 46.8% and 31.1%, respectively. The median follow-up duration was 5.83 years. In patients who received combined therapy including multi-agent chemotherapy and surgical resection of both primary and metastatic lesions, the 5-year OS and EFS reached 70% and 47%, respectively. Key favorable prognostic factors included having no more than 10 metastatic lung lesions and a good histologic response to preoperative chemotherapy at the primary tumor site. Conclusion. The treatment outcomes of patients diagnosed with osteosarcoma and isolated pulmonary metastases in the Russian Federation are comparable to international data. The effectiveness of therapy in this patient group directly depends on the coordinated work of a multidisciplinary team, including pediatric oncologists, orthopedic surgeons, thoracic surgeons, radiologists, and pathologists.
- 19 August 2026
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 25 (3) , 22-33
Open AccessPrognostic factors in pediatric osteosarcoma presenting with pulmonary metastasis: experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
Introduction. Approximately 20% of newly diagnosed pediatric patients with high-grade osteosarcoma present with metastatic disease, with the lungs being the predominant site of dissemination. In the absence of universally accepted criteria for defining pulmonary metastases and assessing the resectability of metastatic lesions, treatment strategies for metastatic osteosarcoma remain highly individualized and depend on the experience of the treating institution. Objective – to evaluate clinicopathological characteristics and outcomes of osteosarcoma patients presenting with pulmonary metastases, and to identify prognostic factors associated with survival. Materials and methods. The study included newly diagnosed pediatric patients with histologically confirmed high-grade osteosarcoma and isolated pulmonary metastases, prospectively registered at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology between January 1, 2012, and December 31, 2023. All patients received specific therapy according to the MAP regimen (based on the EURAMOS-1 protocol). Treatment outcomes were evaluated by event-free survival (EFS) and overall survival (OS) rates, calculated using the Kaplan–Meier method. Results. Among 354 patients with high-grade osteosarcoma, isolated pulmonary metastases were identified in 96 patients (27.1%). The 5-year OS and EFS rates for the entire cohort were 46.8% and 31.1%, respectively. The median follow-up duration was 5.83 years. In patients who received combined therapy including multi-agent chemotherapy and surgical resection of both primary and metastatic lesions, the 5-year OS and EFS reached 70% and 47%, respectively. Key favorable prognostic factors included having no more than 10 metastatic lung lesions and a good histologic response to preoperative chemotherapy at the primary tumor site. Conclusion. The treatment outcomes of patients diagnosed with osteosarcoma and isolated pulmonary metastases in the Russian Federation are comparable to international data. The effectiveness of therapy in this patient group directly depends on the coordinated work of a multidisciplinary team, including pediatric oncologists, orthopedic surgeons, thoracic surgeons, radiologists, and pathologists.
- Open Access
Assessment of the accuracy of lung lesions diagnosis in adolescents with osteosarcoma using artificial intelligence
Background. Lung metastases in osteosarcoma (OS) are the main cause of the death. The accuracy of the diagnosis of nodules by computed tomography (CT) of the lungs is critically important for determining the disseminated stage of the disease and planning surgical treatment. The use of artificial intelligence (AI) in the search for lung nodules increases the accuracy of diagnosis and reduces the chance of missing metastases. Objective: to evaluate the accuracy of lung nodules diagnosis in adolescents with OS using AI. Methods. A retrospective assessment of CT scans of adolescents with OS was performed. A pathological nodule with an average size of ≥4 mm was considered a target finding. The diagnostic accuracy of an AI algorithm previously trained on an adult dataset was evaluated, and the number of false positives (FP) and false negatives (FN) was determined. Sensitivity, specificity, accuracy, area under the ROC curve (AUC), positive predictive value, negative predictive value, and F1-measure were calculated. Based on the obtained results, the effectiveness of the algorithm was assessed. Results. 248 CT scans of adolescents with OS were evaluated. The following results were obtained: in 5 cases, the AI algorithm showed a FP result (2.02%), in 34 cases, it showed a FN result (13.71%), and in 209 cases, a correct result (both true positive and true negative) (84.27%). The diagnostic accuracy of the algorithm was 0.843 (95% CI 0.794-0.887). The application of the AI algorithm in the practice of an X-ray doctor in a specific clinical task would allow to increase the sensitivity from 0.805 to 0.891, while ensuring an absolute decrease in the number of FN results by 8.59% and a relative decrease by 44%. Conclusion. The obtained results confirm the practical value of the application of the AI algorithm and justify the implementation of AI-assisted systems in the diagnostic protocols for lung metastases in adolescents with OS.
Open AccessAssessment of the accuracy of lung lesions diagnosis in adolescents with osteosarcoma using artificial intelligence
Background. Lung metastases in osteosarcoma (OS) are the main cause of the death. The accuracy of the diagnosis of nodules by computed tomography (CT) of the lungs is critically important for determining the disseminated stage of the disease and planning surgical treatment. The use of artificial intelligence (AI) in the search for lung nodules increases the accuracy of diagnosis and reduces the chance of missing metastases. Objective: to evaluate the accuracy of lung nodules diagnosis in adolescents with OS using AI. Methods. A retrospective assessment of CT scans of adolescents with OS was performed. A pathological nodule with an average size of ≥4 mm was considered a target finding. The diagnostic accuracy of an AI algorithm previously trained on an adult dataset was evaluated, and the number of false positives (FP) and false negatives (FN) was determined. Sensitivity, specificity, accuracy, area under the ROC curve (AUC), positive predictive value, negative predictive value, and F1-measure were calculated. Based on the obtained results, the effectiveness of the algorithm was assessed. Results. 248 CT scans of adolescents with OS were evaluated. The following results were obtained: in 5 cases, the AI algorithm showed a FP result (2.02%), in 34 cases, it showed a FN result (13.71%), and in 209 cases, a correct result (both true positive and true negative) (84.27%). The diagnostic accuracy of the algorithm was 0.843 (95% CI 0.794-0.887). The application of the AI algorithm in the practice of an X-ray doctor in a specific clinical task would allow to increase the sensitivity from 0.805 to 0.891, while ensuring an absolute decrease in the number of FN results by 8.59% and a relative decrease by 44%. Conclusion. The obtained results confirm the practical value of the application of the AI algorithm and justify the implementation of AI-assisted systems in the diagnostic protocols for lung metastases in adolescents with OS.
- Open Access
- 2 November 2025
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 12 (3) , 22-38
Results of treatment of patients with posterior mediastinal neuroblastoma in the observation group
Background . Neuroblastoma (NB) with primary tumor located in the posterior mediastinum is a unique subgroup characterized by a higher incidence of life-threatening complications, such as epidural compression (EC) and respiratory failure, yet it is associated with favorable long-term outcomes. Materials and methods . The study included patients with low-risk posterior mediastinal NB treated at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology between January 2012 and September 2024 (152 months). Patients were stratified into risk groups and managed according to the GPOH-NB2004 protocol. We evaluated relapse/progression detection methods, disease characteristics, treatment approaches, and long-term outcomes. Results . The study included 146 patients with NB with primary tumor located in the posterior mediastinum, which is 21.6 % of all patients in the observation (low-risk) group registered in the research database of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. The median age at diagnosis was 19.6 months (range 0.5–132.5 months) with a female predominance (male-to-female ratio 1:1.2). Most patients (85/146; 58.2 %) presented with stage 2 disease. 38/146 (26.0 %) patients received chemotherapy due to life threatening symptoms, primarily EC, while 87/146 (59.6 %) patients underwent best surgery in the volume of a macroscopic residual tumor. Relapse/progression occurred in 16.4 % (24/146), predominantly detected during routine follow-up imaging (18/24; 75,0 %), with a median time to relapse of 7.8 months (range 3.0–25.3 months). The majority of relapses/progressions were local (18/24; 75.0 %). In 93 % (14/15) of relapsed/progressed cases analyzed retrospectively, MLPA revealed segmental chromosomal aberrations (median 3 aberrations/ patient; range 0–6). The most frequent alterations included 17q gain (n = 11), 2p gain (n = 8), and deletions in 3p (n = 6), 11q (n = 5), and 4q (n = 4). The 5-year event-free survival in patients with mediastinal NB was 79,1 ± 4,0 %, patients with stage 1 showing the highest survival rates (90 ± 6 %) (p = 0.1932). The 5-year overall survival was 95,0 ± 2,1 %. The cumulative incidence of relapse/progression was 18.7 ± 3.5 %, while treatment-related mortality was 2.8 ± 1.4 % (one death from disease progression; five from therapy toxicity). Conclusions. Mediastinal NB is a prognostically favorable group, with excellent survival rates independent of age or stage. Most patients in the low-risk group achieved favorable outcomes, even after relapse/progression. For the majority of patients in the low-risk group, surgery only is sufficient, and this strategy allows to reduce the risk of mortality from the toxicity of therapy without reducing overall survival. However, chemotherapy remains critical for patients with life-threatening complications, such as EC and respiratory failure, which once again highlighting the challenges in managing this subgroup. Strict adherence to the entire follow-up plan during the period of catamnesis is essential for early relapse detection. The molecular profile of the tumor may predict relapses and treatment response, which underscores the need to integrate molecular diagnostic methods (MLPA) to all patients with NB in the low-risk group into routine diagnostics.
- 2 November 2025
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 12 (3) , 22-38
Open AccessResults of treatment of patients with posterior mediastinal neuroblastoma in the observation group
Background . Neuroblastoma (NB) with primary tumor located in the posterior mediastinum is a unique subgroup characterized by a higher incidence of life-threatening complications, such as epidural compression (EC) and respiratory failure, yet it is associated with favorable long-term outcomes. Materials and methods . The study included patients with low-risk posterior mediastinal NB treated at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology between January 2012 and September 2024 (152 months). Patients were stratified into risk groups and managed according to the GPOH-NB2004 protocol. We evaluated relapse/progression detection methods, disease characteristics, treatment approaches, and long-term outcomes. Results . The study included 146 patients with NB with primary tumor located in the posterior mediastinum, which is 21.6 % of all patients in the observation (low-risk) group registered in the research database of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. The median age at diagnosis was 19.6 months (range 0.5–132.5 months) with a female predominance (male-to-female ratio 1:1.2). Most patients (85/146; 58.2 %) presented with stage 2 disease. 38/146 (26.0 %) patients received chemotherapy due to life threatening symptoms, primarily EC, while 87/146 (59.6 %) patients underwent best surgery in the volume of a macroscopic residual tumor. Relapse/progression occurred in 16.4 % (24/146), predominantly detected during routine follow-up imaging (18/24; 75,0 %), with a median time to relapse of 7.8 months (range 3.0–25.3 months). The majority of relapses/progressions were local (18/24; 75.0 %). In 93 % (14/15) of relapsed/progressed cases analyzed retrospectively, MLPA revealed segmental chromosomal aberrations (median 3 aberrations/ patient; range 0–6). The most frequent alterations included 17q gain (n = 11), 2p gain (n = 8), and deletions in 3p (n = 6), 11q (n = 5), and 4q (n = 4). The 5-year event-free survival in patients with mediastinal NB was 79,1 ± 4,0 %, patients with stage 1 showing the highest survival rates (90 ± 6 %) (p = 0.1932). The 5-year overall survival was 95,0 ± 2,1 %. The cumulative incidence of relapse/progression was 18.7 ± 3.5 %, while treatment-related mortality was 2.8 ± 1.4 % (one death from disease progression; five from therapy toxicity). Conclusions. Mediastinal NB is a prognostically favorable group, with excellent survival rates independent of age or stage. Most patients in the low-risk group achieved favorable outcomes, even after relapse/progression. For the majority of patients in the low-risk group, surgery only is sufficient, and this strategy allows to reduce the risk of mortality from the toxicity of therapy without reducing overall survival. However, chemotherapy remains critical for patients with life-threatening complications, such as EC and respiratory failure, which once again highlighting the challenges in managing this subgroup. Strict adherence to the entire follow-up plan during the period of catamnesis is essential for early relapse detection. The molecular profile of the tumor may predict relapses and treatment response, which underscores the need to integrate molecular diagnostic methods (MLPA) to all patients with NB in the low-risk group into routine diagnostics.
- Open Access
- 14 October 2025
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 17 (3) , 45-56
Telangiectatic osteosarcoma in children and adolescents: Experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology scientific and clinical group on studying sarcomas of the locomotor system
Introduction. Telangiectatic osteosarcoma is a rare histological subtype of osteosarcoma, accounting for 2–12 % of all cases. Although telangiectatic osteosarcoma is characterized by unique morphological and radiological features, its diagnosis might be challenging due to its similarity to aneurysmal bone cysts and giant cell tumors. Aim. To evaluate oncologic outcomes in a large homogeneous series of children and adolescents with telangiectatic osteosarcoma. Materials and methods. The study included treatment-naive patients under the age of 18 with a diagnosis of telangiectatic osteosarcoma confirmed between January 1, 2012, and December 31, 2023, and prospectively registered at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. All patients received MAP-based chemotherapy (according to the EURAMOS-1 protocol). Treatment outcomes were assessedusing event-free survival and overall survival rates, calculated by the Kaplan–Meier method. Results. Among 368 primary osteosarcoma patients, the telangiectatic subtype was diagnosed in 40 cases (10.8 %). At initial diagnosis, 48.7 % of patients had pulmonary metastases, and pathological fractures were identified in 33.4 % of cases. Histological examination showed good response to preoperative chemotherapy in 76.3 % of patients. The median follow-up was 3.65 years. 5-year overall survival and event-free survival rates for all patients were 73.4 % and 57.3 %, respectively. Conclusion. Due to combination treatment including surgical tumor resection and neo- and adjuvant polychemotherapy, treatment outcomes for patients with telangiectatic osteosarcoma are similar to outcomes in patients with conventional osteosarcoma.
- 14 October 2025
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 17 (3) , 45-56
Open AccessTelangiectatic osteosarcoma in children and adolescents: Experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology scientific and clinical group on studying sarcomas of the locomotor system
Introduction. Telangiectatic osteosarcoma is a rare histological subtype of osteosarcoma, accounting for 2–12 % of all cases. Although telangiectatic osteosarcoma is characterized by unique morphological and radiological features, its diagnosis might be challenging due to its similarity to aneurysmal bone cysts and giant cell tumors. Aim. To evaluate oncologic outcomes in a large homogeneous series of children and adolescents with telangiectatic osteosarcoma. Materials and methods. The study included treatment-naive patients under the age of 18 with a diagnosis of telangiectatic osteosarcoma confirmed between January 1, 2012, and December 31, 2023, and prospectively registered at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. All patients received MAP-based chemotherapy (according to the EURAMOS-1 protocol). Treatment outcomes were assessedusing event-free survival and overall survival rates, calculated by the Kaplan–Meier method. Results. Among 368 primary osteosarcoma patients, the telangiectatic subtype was diagnosed in 40 cases (10.8 %). At initial diagnosis, 48.7 % of patients had pulmonary metastases, and pathological fractures were identified in 33.4 % of cases. Histological examination showed good response to preoperative chemotherapy in 76.3 % of patients. The median follow-up was 3.65 years. 5-year overall survival and event-free survival rates for all patients were 73.4 % and 57.3 %, respectively. Conclusion. Due to combination treatment including surgical tumor resection and neo- and adjuvant polychemotherapy, treatment outcomes for patients with telangiectatic osteosarcoma are similar to outcomes in patients with conventional osteosarcoma.
- Open Access
- 23 April 2025
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 12 (1) , 48-54
Primary malignant lung tumors in children (review of the literature)
Primary malignant lung tumors are an extremely rare pathology in childhood and adolescents.The purpose of this publication – is to review the most complete and significant retrospective studies on this pathology, to explore the epidemiology, clinical symptoms and treatment methods, as well as to assess the prognosis of the disease depending on the histological type of tumor.
- 23 April 2025
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 12 (1) , 48-54
Open AccessPrimary malignant lung tumors in children (review of the literature)
Primary malignant lung tumors are an extremely rare pathology in childhood and adolescents.The purpose of this publication – is to review the most complete and significant retrospective studies on this pathology, to explore the epidemiology, clinical symptoms and treatment methods, as well as to assess the prognosis of the disease depending on the histological type of tumor.
- Open Access
- 28 March 2025
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (1)
Эктопия щитовидной железы в яичник с развитием папиллярного рака с канцероматозом. Описание клинического случая.
Pediatric Hematology/Oncology and Immunopathology | Peer-rewiev medical journal Вопросы гематологии/онкологии и иммунопатологии в педиатрии | Научный рецензируемый журнал
- 28 March 2025
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (1)
Open AccessЭктопия щитовидной железы в яичник с развитием папиллярного рака с канцероматозом. Описание клинического случая.
Pediatric Hematology/Oncology and Immunopathology | Peer-rewiev medical journal Вопросы гематологии/онкологии и иммунопатологии в педиатрии | Научный рецензируемый журнал
- 14 September 2024
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (22) , 161927
Central liver segments resections vs extended hepatectomies in children: Single-center experience
- 14 September 2024
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (22) , 161927
Central liver segments resections vs extended hepatectomies in children: Single-center experience
- Open Access
- 20 December 2023
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 22 (4) , 52-62-62
Resection of the chest wall for bone and soft tissue neoplasms in children
Chest tumors are quite rare in children. Among them there are benign and malignant. In all cases, surgical intervention is needed; in malignant tumors, as a stage of treatment, it is aimed at removing the tumor and, if necessary, reconstructing the chest wall. Due to the different localization, local spread and involvement of underlying structures, the surgical approach may involve a large extent of chest wall resection, and a variety of plastic materials and techniques is quite wide. During the period from September 2012 to January 2022, 43 surgical interventions for neoplasms of the chest wall in children were performed in the Department of Oncology and Pediatric Surgery of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. In 11 (26.8%) cases, neoplasms were benign, 30 (73.2%) patients underwent surgical treatment for malignant tumors of various histogenesis. The surgery of the chest wall consisted of two stages. The first stage was a wide excision of the tumor within healthy tissues, performed en bloc with the involvement of underlying tissues and organs (diaphragm). If a malignant process and lung foci were detected, we simultaneously removed the foci on the affected side. The second stage was the reconstruction of the chest wall and diaphragm with local tissues or with the use of non-absorbable synthetic material (polymer meshes, dermal-derived bioprostheses, titanium meshes) shaped according to the size of the defect with a margin for fixation to the edges of the wound. Overall and relapse-free survival was evaluated. The maximum observation period was 9 years. The operative approach and the extent of surgical intervention depend on the size of the primary tumor site and its spread (multifocal lesion), the involvement of adjacent anatomical structures and are individual in each case. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology.
- 20 December 2023
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 22 (4) , 52-62-62
Open AccessResection of the chest wall for bone and soft tissue neoplasms in children
Chest tumors are quite rare in children. Among them there are benign and malignant. In all cases, surgical intervention is needed; in malignant tumors, as a stage of treatment, it is aimed at removing the tumor and, if necessary, reconstructing the chest wall. Due to the different localization, local spread and involvement of underlying structures, the surgical approach may involve a large extent of chest wall resection, and a variety of plastic materials and techniques is quite wide. During the period from September 2012 to January 2022, 43 surgical interventions for neoplasms of the chest wall in children were performed in the Department of Oncology and Pediatric Surgery of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. In 11 (26.8%) cases, neoplasms were benign, 30 (73.2%) patients underwent surgical treatment for malignant tumors of various histogenesis. The surgery of the chest wall consisted of two stages. The first stage was a wide excision of the tumor within healthy tissues, performed en bloc with the involvement of underlying tissues and organs (diaphragm). If a malignant process and lung foci were detected, we simultaneously removed the foci on the affected side. The second stage was the reconstruction of the chest wall and diaphragm with local tissues or with the use of non-absorbable synthetic material (polymer meshes, dermal-derived bioprostheses, titanium meshes) shaped according to the size of the defect with a margin for fixation to the edges of the wound. Overall and relapse-free survival was evaluated. The maximum observation period was 9 years. The operative approach and the extent of surgical intervention depend on the size of the primary tumor site and its spread (multifocal lesion), the involvement of adjacent anatomical structures and are individual in each case. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology.